Outlook Therapeutics Inc (OTLK)
8.50
-0.10
(-1.16%)
USD |
NASDAQ |
May 06, 16:00
Outlook Therapeutics Cash from Operations (TTM): -47.10M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -47.10M |
| September 30, 2023 | -42.97M |
| June 30, 2023 | -40.48M |
| March 31, 2023 | -48.37M |
| December 31, 2022 | -54.59M |
| September 30, 2022 | -56.67M |
| June 30, 2022 | -55.41M |
| March 31, 2022 | -54.51M |
| December 31, 2021 | -51.92M |
| September 30, 2021 | -54.25M |
| June 30, 2021 | -57.34M |
| March 31, 2021 | -43.10M |
| December 31, 2020 | -38.44M |
| September 30, 2020 | -31.79M |
| June 30, 2020 | -25.65M |
| March 31, 2020 | -30.01M |
| December 31, 2019 | -29.18M |
| Date | Value |
|---|---|
| September 30, 2019 | -32.29M |
| June 30, 2019 | -34.74M |
| March 31, 2019 | -32.97M |
| December 31, 2018 | -34.15M |
| September 30, 2018 | -33.04M |
| June 30, 2018 | -24.57M |
| March 31, 2018 | -21.66M |
| December 31, 2017 | -18.33M |
| September 30, 2017 | -15.51M |
| June 30, 2017 | -25.96M |
| March 31, 2017 | -36.36M |
| December 31, 2016 | -39.31M |
| September 30, 2016 | -45.48M |
| June 30, 2016 | -46.13M |
| March 31, 2016 | -40.12M |
| December 31, 2015 | -35.82M |
| September 30, 2015 | -27.48M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-57.34M
Minimum
Jun 2021
-25.65M
Maximum
Jun 2020
-43.62M
Average
-43.10M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| Cutera Inc | -137.64M |
| Actinium Pharmaceuticals Inc | -39.63M |
| GT Biopharma Inc | -8.852M |
| Karyopharm Therapeutics Inc | -92.72M |
| Marinus Pharmaceuticals Inc | -118.00M |